2014 First market authorisation in Europe for API manufactured at Polymun (biosimilar rhFSH for Finox Biotech AG, Switzerland)
2013 First inspection by FDA
2011 Start of operations at the new company site of Polymun in Klosterneuburg
2010 Beginning of construction of a new company site for Polymun
2004 First clinical study under IND of the FDA with the triple combination of HIV antibodies
2001 Polymun licensed as manufacturer of biopharmaceuticals according the Austrian Pharmaceutical Law §63
2000 Adaptation of the fermentation facility to full GMP compliance.
First successful selection of high producing cell clones by FACS-sorting
Patent applied for the liposome production technology
1999 Routine use of protein and animal-component-free systems for cryopreservation and propagation of animal cells including hybridoma, Vero and CHO cells
1994 Use of ultrasonic retention device for perfusion (Gaida, Doblhoff-Dier, Strutzenberger, Katinger, Burger, Handl, Gröschl & Benes 1996, Biotechnology Progress 73)
1992 Founding of Polymun
PROF. HERMANN KATINGER
Prof. Hermann Katinger, born 1941, has long term experience in the field of microbiology and biotechnology. In the beginning of his scientific career the focus was on yeast fermentation, graduating with a Master degree in 1966 and a Ph.D. in 1971. His further work was dedicated to large scale fermentation for industrial applications for which he was promoted to associate professor at the University of Natural Resources and Life Sciences, Vienna, in 1977.
It was during this time that he started to expand his interests to mammalian cell culture developing a new type of fermenter for mass cultivation, the airlift bioreactor. In 1976 he was founding member of ESACT, the European Society for Animal Cell Technology.
MEET US AT
Tides: Oligonucleotide and Peptide Therapeutics
May 20-23, 2019
San Diego, CA, USA
Dr. Andreas Wagner
Controlled Release Society Annual Meeting & Exposition
July 21-24, 2019
Dr. Andreas Wagner
Harald Loidl, BSc BA